A B S T R A C T Histamine, one of the mediators involved in the IgE-mediated reaction, was demonstrated to influence in vivo and in vitro components of cellularimmune reactions in orthochlorobenzoyl-bovine gamma globulin-immune guinea pigs. 10' M histamine reduced by half the size of a delayed hypersensitivity skin test at 24 h. Inhibition of skin reactivity by histamine could be partially reversed by H-1 receptor antagonists such as chlorpheniramine and completely prevented by H-2 receptor antagonists such as burimamide. The histamine suppression of cutaneous delayed hypersensitivity could be accounted for in part by its inhibitory effect on certain lymphocyte responses including antigen-induced migration inhibitory factor (MIF) production and proliferation. At concentrations of OV-10' M, histamine reversibly inhibited MIF production and its action could be blocked by H-2 antagonists but not H-1 antagonists. Thus, lymphocytes bearing H-2 receptors modulate MIF production and probably lymphocyte proliferation as well. Histamine did not interfere with the macrophage response to preformed MIF. These studies indicate that immediate hypersensitivity reactions involving histamine release might influence the subsequent expression of cellular-immune reactions.
INTRODUCTION
Specific receptors for a variety of hormones have recently been detected on the membranes of a number of distinct cell types. Some of these include receptors for vasopressin, growth hormone, insulin, and histamine (1, 2) . Histamine receptors modulate several functions of leukocytes such as antibody production (3), basophil histamine release (4) , and lymphocyte-mediated cytotoxicity (5) . Ash and Schild demonstrated that the physiologic activities of histamine are mediated by at least two different receptors (6) . The H-1 receptor mediates the contraction of intestinal and bronchial smooth muscle and the dilatation of small venules. Its effects are blocked by standard antihistamines such as mepryamine and diphenhydramine. The H-2 receptor mediates gastric acid secretion and relaxes rat uterine muscle. The latter is antagonized by a different class of antihistamines characterized by thiourea derivatives such as burimamide and metiamide (7). Plaut et al. have shown that the allogeneic lymphocyte cytotoxic reaction is regulated. by cells bearing receptors of the H-2 variety (8) .
In the present report, the effects of histamine were evaluated on several facets of the cellular-immune reaction in the guinea pig: the delayed hypersensitivity (DHS) 1 skin test, the antigen-induced lymphocyte proliferative response and production of macrophage migration inhibitory factor (MIF), and the response of macrophages to preformed MIF. Histamine was shown to diminish the size of a DHS skin test but not completely suppress its development. The inhibition of cutaneous DHS by histamine could be prevented by H-2 receptor antagonists such as burimamide but not by H-1 receptor blockers such as chlorpheniramine. Histamine reversibly suppressed MIF production by immune guinea pig lymphocytes and this effect was mediated by H-2 receptor-bearing cells. The lymphocyte proliferative response was only partially inhibited by histamine and the macrophage response to preformed MIF was not influenced at all. (9) . The popliteal, axillary, and inguinal lymph nodes were teased using a mouse tooth forceps. The sediment was discarded and the cells washed twice in medium TC-199 containing 100 U of penicillin/ml and 100 gg of streptomycin/ml. Viability (60-70%) was determined by trypan blue exclusion. The final cell concentration was adjusted to 2.4 X 107 cells/ml in medium TC-199 without serum. The cell suspension was divided into two aliquots; to one aliquot, 100 /Ag/ml OCB-BGG was added and to the other saline was added. Varying concentrations of drugs were added along with antigen or at varying times afterward. The cell suspensions were incubated for 24 h at 370C in a 5%o C02-95% air atmosphere. The cell-free supernates were obtained by centrifugation and made to contain 15% guinea pig serum by volume. These supernates were assayed for MIF activity using normal guinea pig PEC in capillary tubes as described above. The percent migration inhibition was calculated using the above formula.
METHODS
Lymphocyte proliferation. Lymph node lymphocytes from OCB-BGG immune animals were cultured in vitro for [3H] thymidine incorporation (10) . 107 cells/2.0 ml were cultured in TC-199 containing 15% normal guinea pig serum and 50 ,tg/ml OCB-BGG with or without drugs for 4 days at 370C in a 5% C02-95% air atmosphere. 2 uCi/tube was added to the cultures 18 h before their termination. The DNA was extracted and the radioactivity determined by scintillation counting. The mean (cpm) of triplicate cultures were recorded and a stimulation index calculated from the ratio of cpm of antigen-stimulated cultures/cpm of unstimulated cultures. The effect of histamine and antihistamines on antigen-induced lymphocyte proliferation was compared to untreated cultures.
RESULTS
Effect of histamine on 24-h DHS skin tests. OCB-BGG-immunized guinea pigs were skin tested for the was added to the antigen preparation. In some experiments burimamide or chlorpheniramine were also added to the preparation. (10' M) significantly reduced the area of the skin reaction by 43% (P <0.01). Burimamide, in equimolar concentrations, completely restored the area to control values.
However, chlorpheniramine (10' M) only partially corrected this suppression. Burimamide alone had no effect on the size of the skin reaction while chlorpheniramine alone reduced the size of the skin test slightly.
Effect of histamine on the direct migration inhibition assay. As a screening procedure, the effects of histamine on the direct migration inhibition system were evaluated first. PECs from OCB-BGG-immune guinea pigs were placed in capillary tubes and varying concentrations of antigen and histamine were added. Table  III summarizes the results of 12 experiments in which 10-' M histamine was present in the assay system for the entire incubation period. In the absence of histamine, a dose response to antigen was obtained. In the presence of 10' MI histamine, the amount of migration inhibition at each antigen concentration was significantly reduced. This effect was also seen with 10' M histamine at the lowest concentration of antigen (Table  IV) . Indeed, the maximal effect of histamine on reducing the migration inhibition was greatest at the lower concentrations of antigen.
Since it has previously been shown that the in vitro Ability of H-1 and H-2 receptor antihistamines to block histamine inhibition of skin test reactivity;
OCB-BGG-immune guinea pigs injected intradermally with 50 jig of specific antigen plus histamine plus antihistamine. * Significant change (P < 0.01).
Modulation of Cellular-Immunity by Histamine Fig. 1 summarizes the results of eight experiments in which the ability of various types of antihistamines to antagonize the histamine effect is measured. Histamine alone (closed circles) significantly reduces the migration inhibition at each antigen concentration compared to the control migration (open circles). Note that burimamide (an H-2 receptor antihistamine), in equimolar concentrations with histamine, can completely reverse the effects of histamine. Similar results were found using the drug metiamide (not shown) which is another H-2 receptor antagonist. In contrast, chlorpheniramine and diphenhydramine, H-1 receptor blockers, did not significantly rereverse the histamine effect. Effects of histamine on the indirect migration inhibition assay. There is no way to determine from the above experiments whether histamine is operating at the level of the lymphocyte or the macrophage. There- * Mean ±SEM fore, the indirect migration inhibition system was employed. The effects of histamine on the macrophage response to preformed MIF is shown in Table V . MIF and control supernates were prepared without histamine being present in the culture. 10' M histamine was then added to these supernates at the time of assay. The results in five of six experiments show that the presence of histamine in the MIF-containing supernates did not significantly interfere with the macrophage response to MIF in terms of migration inhibition. Whether histamine suppresses MIF production by guinea pig lymphocytes was investigated next. Lymph node lymphocytes from sensitized animals were incubated with 100 Mg/ml of OCB-BGG in the presence or absence of varying amounts of histamine for 24 h. The cell-free supernates were dialyzed and assayed on nonimmune PEC. Fig. 2 makes two points: histamine inhibits MIF production in a dose-response fashion and also shows the ability of certain antihistamines to reverse the effect of histamine on MIF production. Histamine significantly depressed lymphocyte MIF production and this effect occurs maximally between 10' and 10' M histamine. Moreover, burimamide can effectively return MIF production to normal, but not chlorpheniramine or diphenhydramine.
Reversibility of the effects of histamine on MIF production. Lymphocytes cultured in the absence of histamine for 24 h produce MIF whether or not they receive additional antigen for 24 h (Fig. 3g and h ). In contrast, cells cultured with histamine for 48 h do not produce MIF (Fig. 3a and b) . However, lymphocytes initially cultured with histamine and antigen for 24 h, washed, and recultured are able to make MIF only if fresh antigen is added ( Fig. 3e and f) . The addition of histamine to cultures of lymphocytes already making (10-3 M) and MIF produced by OCB-BGG-immune lymph node lymphocytes.
MIF for 24 h does not prevent further MIF production for another 24 h ( Fig. 3c and d) .
The point at which histamine exerts its effect on MAIF production was next determined. Lymph node cells were cultured with antigen and 10-' M histamine added at varying times afterward (Fig. 4) . When (Table VI) . Lower concentrations of histamine were less suppressive and 10' M histamine significantly reduced radiolabel uptake in unstimulated cultures. Burimamide (not shown) effectively restores the response to control values but chlorpheniramine was unable to reverse the histamine effect.
DISCUSSION
Histamine, a mediator usually released through IgEmediated reactions, was shown to partially diminish the expression of DHS in the skin and to profoundly alter certain lymphocyte functions in vitro. Concentrations 30- (5) T. histamine exerts its effects on DHS skin reactions via mechanisms involving vascular permeability (i.e., "washout" of antigen from the skin site) or through its effect on lymphocyte function, or a combination of the two. The observation that chlorpheniramine (an agent which blocks histamine's effects on vascular permeability) partially restores the skin response and that burimamide (reverses histamine's effects on lymphocyte function) completely returns it to control values suggests that both mechanisms may be involved. While it is difficult to determine how histamine influences DHS by means of skin testing, an examination of its in vitro effects on certain lymphocyte and macrophage functions related to DHS provide more information. In a dose-response fashion, histamine suppressed antigen-induced lymphocyte MIF production and proliferation. Whereas concentrations of 10' to 10' M histamine completely inhibited MIF production by OCB-BGG-immune guinea pig lymphocytes, [3H]thymidine incorporation was only partially suppressed (30-40%). It is possible that histamine only partially inhibits proliferation because the kinetics of the response are much longer than those relating to MIF production. Histamine may be inactivated very early in the proliferative response and cells may then begin to undergo activation. Whereas MIF production is measured at 24 h rather than at 4 days as is proliferation. In contrast to the results obtained with skin reactions, only H-2 receptor antagonists such as burimamide and metiamide blocked the suppressive effects of histamine on lymphocyte MIF production and proliferation. Chlorpheniramine and diphenhydramine (H-1 receptor antagonists) failed to prevent histamine's action on these two in vitro cellularimmune responses. These findings indicate that lymphocytes with H-2 receptors affect MIF production and probably proliferation as well and adds yet another leukocyte function influenced by cells bearing these receptors (3) (4) (5) .
Histamine reversibly inhibits MIF production; cells initially cultured with histamine for 24 h and then washed free of the drug and recultured with antigen for another 24 h can be stimulated to produce MIF (Fig. 3) . Cells cultured initially with antigen but without histamine for 24 h will continue to produce MIF for another 24 h without antigen being readded to the cultures. If, however, cells are cultured with antigen and histamine for 24 h, washed, and recultured without adding further antigen for another 24 h, then MIF is not made. In contrast, cells actively producing MIF for 24 h continue to do so -despite the addition of histamine to the culture. Moreover, adding histamine up to an hour after specific antigen has been initially presented to sensitized cells will significantly reduce MIF production. After this time, however, the addition of histamine does not significantly alter MIF production. These findings, taken together, indicate that histamine exerts its effects at an early step in the MIF response, perhaps interfering with an antigen-dependent step. A similar observation has recently been made by Daniels et The present experiments were initiated because of a previous study which showed that lymphocytes from the majority of patients with ragweed hay fever-produced mediators (MIF and mitogenic factor) and underwent a proliferative response to ragweed antigen E despite having absent delayed cutaneous reactivity to ragweed antigen (20) . Of particular interest, all of these patients had strong immediate wheal and flare reactions to ragweed which could be reduced by 50% using a standard H-1 antihistamine such as chlorpheniramine maleate. Despite the reduction in the size of the immediate reaction, no cutaneous DHS developed at the same site. It is possible that the release of histamine at the immediate hypersensitivity skin site suppressed the subsequent development of a DHS reaction. Furthermore, the results presented here suggest that the use of an H-2 receptor antagonist such as burimamide at the skin site instead of an H-1 receptor antagonist might be effective in allowing the expression of cutaneous DHS. Therefore, the investigator should be aware that IgE-mediated reactions to any antigen may interfere with the subsequent development of a DHS reaction at the same site.
Studies are presently being carried out in man to determine whether human MIF production is altered by histamine. Preliminary results suggest that antigeninduced MIF production by human lymphocytes also is suppressed by histamine using the indirect migration inhibition test. It is not clear as yet whether histamine alters the response of human mionocytes to preformed human MIF.
